Showing results (261-270 of 303) with videos related to
Sort By:
Pageof 31
Alimentary Pharmacology & Therapeutics|August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg LossSimon J Hume, Samuel Hall, Gareth Burns, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 16, 2020
Platelet activating factor receptor acts to limit colitis-induced liver inflammationGang Liu, Alan W Baird, Marie J Parsons, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 8, 2021
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New ZealandJess Howell, Avik Majumdar, Michael A Fink, et al.Journal of Hepatology|March 20, 2018
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosisMassimo Puoti, Graham R Foster, Stanley Wang, et al.Nature Communications|March 15, 2024
Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluationMarti Cabanes-Creus, Sophia H Y Liao, Renina Gale Navarro, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2017
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimensK Rajender Reddy, Stanislas Pol, Paul J Thuluvath, et al.Annals of Internal Medicine|November 10, 2015
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized TrialStephen Pianko, Steven L Flamm, Mitchell L Shiffman, et al.Trials|November 7, 2024
Implementing palliative care in hepatocellular carcinoma ambulatory clinics-study protocol for Accelerated translational research in PRImary liver CAncer (APRICA) randomised controlled palliative care trialCameron Gofton, Anna Di Bartolomeo, Rose Boutros, et al.Molecules (Basel, Switzerland)|November 21, 2020
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2Cecy R Xi, Arianna Di Fazio, Naveed Ahmed Nadvi, et al.Digestive Diseases and Sciences|May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment CohortPaul J Clark, Patricia C Valery, Simone I Strasser, et al.Pageof 31